Controlling Triglycerides in Type 2 Diabetes Cuts CVD Risk
Hypertriglyceridaemia is a prevalent risk factor for cardiovascular disease (CVD) and increasingly important in the setting of current obesity and insulin resistance epidemics. Statins are the primary drug treatment option, however, trial data show substantial ‘residual risk’ in people with type 2 diabetes (T2D) who are on statin treatment. This indicates that preventative treatment with statins alone may not be enough in people with T2D and additional therapies, such as fibrates, may need to be considered.
Modern Medicine – Issue 6 2021
